TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | -1 | -3 | 7 | 11 | 8 | -9 | 2 |
| P | %wins | 33 | 0 | 100 | 67 | 33 | 0 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/3/22 16:42 | 9/29/22 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tyson Timothy | MA | D | P.m | 106 | 6.26 | 0 | 17 | 212 | 25 | D | |||||||||||||||
8/10/05 15:04 | 8/10/05 | VRX | Valeant Pharmaceuticals International | DE | Health | Drug | Pharmaceutical Preparations | Tyson Timothy | CA | DO | CEO,P | P | 40 | 19.85 | 12 | 2 | 17 | 14 | D | -55 | 17 | 3 | 13 | 9 | 15 | 12 | -3 | 1 | -2 | 3 | 47 | 42 | -6 |
3/16/04 12:05 | 3/15/04 | VRX | Valeant Pharmaceuticals International | DE | Health | Drug | Pharmaceutical Preparations | Tyson Timothy | CA | O | P, COO | P | 49 | 24.64 | 33 | 2 | 24 | 10 | D | -65 | -57 | -60 | -14 | -22 | -13 | -7 | -2 | -1 | -3 | 2 | 3 | -4 | -1 |
12/15/03 14:18 | 12/12/03 | VRX | Valeant Pharmaceuticals International | DE | Health | Drug | Pharmaceutical Preparations | Tyson Timothy | CA | O | P, COO | P | 206 | 24.65 | 33 | 8 | New | 8 | D | -62 | -32 | -59 | -52 | -16 | 7 | 21 | 13 | -2 | -4 | 15 | -17 | -15 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |